PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Alibaba Health Information Technology Limited (ALB...
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Sector

Healthcare

Highlights

Market Cap

$7.06B

EPS (TTM)

$0.21

PE Ratio

41.50

PEG Ratio

1.01

Total Revenue (TTM)

$14.07B

Gross Profit (TTM)

$3.03B

EBITDA (TTM)

$389.04M

Year Range

$6.88 - $15.65

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alibaba Health Information Technology Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember
12.18%
6.22%
ALBBY (Alibaba Health Information Technology Limited)
Benchmark (^GSPC)

Returns By Period

Alibaba Health Information Technology Limited had a return of 0.00% year-to-date (YTD) and -19.31% in the last 12 months.


ALBBY

YTD

0.00%

1M

-5.48%

6M

12.16%

1Y

-19.31%

5Y*

-13.08%

10Y*

N/A

^GSPC (Benchmark)

YTD

0.00%

1M

-2.50%

6M

6.76%

1Y

23.31%

5Y*

12.57%

10Y*

11.09%

*Annualized

Monthly Returns

The table below presents the monthly returns of ALBBY, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-25.93%8.87%3.33%-23.44%26.80%-1.33%-3.44%-9.65%59.57%-14.17%-10.49%-19.31%
20237.92%-24.91%1.29%0.00%-12.44%-5.28%17.21%-24.11%16.12%-6.32%4.21%-10.96%-38.88%
2022-8.52%-6.15%-6.68%-24.40%5.76%29.32%-4.45%-12.29%-19.50%-8.76%93.01%8.47%6.77%
20213.96%8.85%-16.00%5.88%-19.07%-7.24%-32.08%7.35%-19.90%-5.57%-27.46%-10.25%-72.88%
20200.00%0.00%0.00%0.00%193.45%18.35%0.08%-18.03%-6.02%15.13%-4.74%18.40%247.69%
20190.00%0.00%0.00%0.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALBBY is 36, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ALBBY is 3636
Overall Rank
The Sharpe Ratio Rank of ALBBY is 3434
Sharpe Ratio Rank
The Sortino Ratio Rank of ALBBY is 3636
Sortino Ratio Rank
The Omega Ratio Rank of ALBBY is 3737
Omega Ratio Rank
The Calmar Ratio Rank of ALBBY is 3737
Calmar Ratio Rank
The Martin Ratio Rank of ALBBY is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Alibaba Health Information Technology Limited (ALBBY) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ALBBY, currently valued at -0.28, compared to the broader market-4.00-2.000.002.00-0.281.84
The chart of Sortino ratio for ALBBY, currently valued at 0.03, compared to the broader market-4.00-2.000.002.004.000.032.48
The chart of Omega ratio for ALBBY, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.34
The chart of Calmar ratio for ALBBY, currently valued at -0.21, compared to the broader market0.002.004.006.00-0.212.75
The chart of Martin ratio for ALBBY, currently valued at -0.69, compared to the broader market0.005.0010.0015.0020.0025.00-0.6911.85
ALBBY
^GSPC

The current Alibaba Health Information Technology Limited Sharpe ratio is -0.28. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Alibaba Health Information Technology Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember
-0.28
1.84
ALBBY (Alibaba Health Information Technology Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Alibaba Health Information Technology Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember
-88.97%
-3.43%
ALBBY (Alibaba Health Information Technology Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alibaba Health Information Technology Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alibaba Health Information Technology Limited was 91.29%, occurring on Apr 15, 2024. The portfolio has not yet recovered.

The current Alibaba Health Information Technology Limited drawdown is 88.97%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.29%Feb 18, 2021794Apr 15, 2024
-24.33%Aug 31, 20206Sep 8, 202064Dec 8, 202070
-22.61%Dec 22, 20204Dec 28, 202015Jan 20, 202119
-12.55%Jan 22, 20216Jan 29, 202111Feb 16, 202117
-2.79%Jul 6, 20201Jul 6, 20203Jul 9, 20204

Volatility

Volatility Chart

The current Alibaba Health Information Technology Limited volatility is 16.93%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AugustSeptemberOctoberNovemberDecember
16.93%
4.15%
ALBBY (Alibaba Health Information Technology Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alibaba Health Information Technology Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Alibaba Health Information Technology Limited compared to its peers in the Pharmaceutical Retailers industry.


PE Ratio
15.020.025.030.035.040.041.5
The chart displays the price to earnings (P/E) ratio for ALBBY in comparison to other companies of the Pharmaceutical Retailers industry. Currently, ALBBY has a PE value of 41.5. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
1.02.03.01.0
The chart displays the price to earnings to growth (PEG) ratio for ALBBY in comparison to other companies of the Pharmaceutical Retailers industry. Currently, ALBBY has a PEG value of 1.0. This PEG ratio falls in the average range for the industry.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Alibaba Health Information Technology Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab